Bionano to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference
SAN DIEGO, Jan. 31, 2024 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq:BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will participate in the BTIG Snowbird MedTech, Digital Health, Life Science & Diagnostic Tools Conference, which will take place February 13-14, 2024.
Related news for (BNGO)
- Don’t Miss Out: MoBot’s Latest Stock Updates 04/10/25 03:00 PM
- Don’t Miss Out: MoBot’s Latest Stock Updates 04/10/25 02:00 PM
- Don’t Miss Out: MoBot’s Latest Stock Updates 04/10/25 01:00 PM
- Bionano Announces Publication of Interim Readout from Second Phase of Clinical Trial Analyzing Optical Genome Mapping as Standard of Care (SOC) for Prenatal Testing